CoChat

Mechanism for the activation of the anaplastic lymphoma kinase receptor

Open access
Reshetnyak, Andrey V., Rossi, Paolo, Myasnikov, Alexander G., Sowaileh, Munia, Mohanty, Jyotidarsini, Nourse, Amanda, Miller, Darcie J., Lax, Irit, Schlessinger, Joseph, Kalodimos, Charalampos G. · 2021 · Nature
Cited by 69

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) that regulates important functions in the central nervous system1,2. The ALK gene is a hotspot for chromosomal translocation events that result in several fusion proteins that cause a variety of human malignancies3. Somatic and germline gain-of-function mutations in ALK were identified in paediatric neuroblastoma4–7. ALK is composed of an extracellular region (ECR), a single transmembrane helix and an intracellular tyrosine kinase domain8,9. ALK is activated by the binding of ALKAL1 and ALKAL2 ligands10–14 to its ECR, but the lack of structural information for the ALK-ECR or for ALKAL ligands has limited our understanding of ALK activation. Here we used cryo-electron microscopy, nuclear magnetic resonance and X-ray crystallography to determine the atomic details of human ALK dimerization and activation by ALKAL1 and ALKAL2. Our data reveal a mechanism of RTK activation that allows dimerization by either dimeric (ALKAL2) or monomeric (ALKAL1) ligands. This mechanism is underpinned by an unusual architecture of the receptor–ligand complex. The ALK-ECR undergoes a pronounced ligand-induced rearrangement and adopts an orientation parallel to the membrane surface. This orientation is further stabilized by an interaction between the ligand and the membrane. Our findings highlight the diversity in RTK oligomerization and activation mechanisms. Cryo-electron microscopy, nuclear magnetic resonance and X-ray crystallography are used to provide structural and mechanistic details of the activation of anaplastic lymphoma kinase by the ligands ALKAL1 and ALKAL2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-021-04140-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 56

  1. Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263, 1281–1284 (1994). · DOI · Paper page
  2. Orthofer, M. et al. Identification of ALK in thinness. Cell 181, 1246–1262 (2020). · DOI · Paper page
  3. Hallberg, B. & Palmer, R. H. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat. Rev. Cancer 13, 685–700 (2013). · DOI · Paper page
  4. Chen, Y. et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455, 971–974 (2008). · DOI · Paper page
  5. Janoueix-Lerosey, I. et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967–970 (2008). · DOI · Paper page
  6. Morris, S. W. et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14, 2175–2188 (1997). · DOI · Paper page
  7. Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 (2010). · DOI · Paper page
  8. Zhang, H. et al. Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome. Proc. Natl Acad. Sci. USA 111, 15741–15745 (2014). · DOI
  9. Guan, J. et al. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase. eLife 4, e09811 (2015). · DOI
  10. Reshetnyak, A. V. et al. Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: hierarchy and specificity of ligand–receptor interactions. Proc. Natl Acad. Sci. USA 112, 15862–15867 (2015). · DOI · Paper page
  11. Mo, E. S., Cheng, Q., Reshetnyak, A. V., Schlessinger, J. & Nicoli, S. Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk. Proc. Natl Acad. Sci. USA 114, 12027–12032 (2017). · DOI · Paper page
  12. Fadeev, A. et al. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells. Proc. Natl Acad. Sci. USA 115, E630–E638 (2018). · DOI · Paper page
  13. Reshetnyak, A. V. et al. Identification of a biologically active fragment of ALK and LTK-ligand 2 (augmentor-α). Proc. Natl Acad. Sci. USA 115, 8340–8345 (2018). · DOI
  14. Crick, F. H. & Rich, A. Structure of polyglycine II. Nature 176, 780–781 (1955). · DOI · Paper page
  15. Warkentin, E. et al. A rare polyglycine type II-like helix motif in naturally occurring proteins. Proteins 85, 2017–2023 (2017). · DOI
  16. Loren, C. E. et al. A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster. EMBO Rep. 4, 781–786 (2003). · DOI · Paper page
  17. Endres, N. F. et al. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152, 543–556 (2013). · DOI · Paper page
  18. Myers, K. V., Amend, S. R. & Pienta, K. J. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol. Cancer 18, 94 (2019). · DOI · Paper page
  19. Grasberger, B., Minton, A. P., DeLisi, C. & Metzger, H. Interaction between proteins localized in membranes. Proc. Natl Acad. Sci. USA 83, 6258–6262 (1986). · DOI · Paper page
  20. Klein, P., Mattoon, D., Lemmon, M. A. & Schlessinger, J. A structure-based model for ligand binding and dimerization of EGF receptors. Proc. Natl Acad. Sci. USA 101, 929–934 (2004). · DOI · Paper page
  21. Kuriyan, J. & Eisenberg, D. The origin of protein interactions and allostery in colocalization. Nature 450, 983–990 (2007). · DOI · Paper page
  22. Diwanji, D., Thaker, T. & Jura, N. More than the sum of the parts: toward full-length receptor tyrosine kinase structures. IUBMB Life 71, 706–720 (2019). · DOI
  23. Murray, P. B. et al. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK. Sci. Signal. 8, ra6 (2015). · DOI
  24. Li, T. et al. Structural basis for ligand reception by anaplastic lymphoma kinase. Nature https://doi.org/10.1038/s41586-021-04141-7 (2021). · DOI
  25. Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L. & Clardy, J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229, 105–124 (1993). · DOI · Paper page
  26. Monneau, Y. R. et al. Exploiting E. coli auxotrophs for leucine, valine, and threonine specific methyl labeling of large proteins for NMR applications. J. Biomol. NMR 65, 99–108 (2016). · DOI
  27. Rossi, P., Monneau, Y. R., Xia, Y., Ishida, Y. & Kalodimos, C. G. Toolkit for NMR studies of methyl-labeled proteins. Methods Enzymol. 614, 107–142 (2019). · DOI
  28. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997). · DOI · Paper page
  29. Hendrickson, W. A. & Ogata, C. M. Phase determination from multiwavelength anomalous diffraction measurements. Methods Enzymol. 276, 494–523 (1997). · DOI · Paper page
  30. Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. D 65, 582–601 (2009). · DOI · Paper page
  31. Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019). · DOI · Paper page
  32. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010). · DOI · Paper page
  33. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995). · DOI · Paper page
  34. Lee, W., Tonelli, M. & Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 31, 1325–1327 (2015). · DOI · Paper page
  35. Lange, O. F. et al. Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples. Proc. Natl Acad. Sci. USA 109, 10873–10878 (2012). · DOI · Paper page
  36. Shen, Y. & Bax, A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR 56, 227–241 (2013). · DOI · Paper page
  37. Monneau, Y. R. et al. Automatic methyl assignment in large proteins by the MAGIC algorithm. J. Biomol. NMR 69, 215–227 (2017). · DOI · Paper page
  38. Guntert, P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353–378 (2004).
  39. Linge, J. P., Williams, M. A., Spronk, C. A., Bonvin, A. M. & Nilges, M. Refinement of protein structures in explicit solvent. Proteins 50, 496–506 (2003). · DOI · Paper page
  40. Brunger, A. T. Version 1.2 of the Crystallography and NMR system. Nat. Protoc. 2, 2728–2733 (2007). · DOI · Paper page
  41. Bhattacharya, A., Tejero, R. & Montelione, G. T. Evaluating protein structures determined by structural genomics consortia. Proteins 66, 778–795 (2007). · DOI · Paper page
  42. Tejero, R., Snyder, D., Mao, B., Aramini, J. M. & Montelione, G. T. PDBStat: a universal restraint converter and restraint analysis software package for protein NMR. J. Biomol. NMR 56, 337–351 (2013). · DOI · Paper page
  43. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005). · DOI · Paper page
  44. Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017). · DOI · Paper page
  45. Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018). · DOI · Paper page
  46. Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing. eLife 7, e35383 (2018). · DOI · Paper page
  47. Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017). · DOI · Paper page
  48. Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004). · DOI · Paper page
  49. Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018). · DOI · Paper page
  50. Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018). · DOI · Paper page
  51. Kortt, A. A., Nice, E. & Gruen, L. C. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis. Anal. Biochem. 273, 133–141 (1999). · DOI
  52. Zhao, H., Brautigam, C. A., Ghirlando, R. & Schuck, P. Overview of current methods in sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation. Curr. Protoc. Protein Sci.71, 20.12.1–20.12.49 (2013). · DOI · Paper page
  53. Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606–1619 (2000). · DOI · Paper page
  54. Zhao, H. et al. A multilaboratory comparison of calibration accuracy and the performance of external references in analytical ultracentrifugation. PLoS ONE 10, e0126420 (2015). · DOI
  55. Brautigam, C. A. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Methods Enzymol. 562, 109–133 (2015). · DOI · Paper page
  56. Folta-Stogniew, E. & Williams, K. R. Determination of molecular masses of proteins in solution: implementation of an HPLC size exclusion chromatography and laser light scattering service in a core laboratory. J. Biomol. Tech. 10, 51–63 (1999).

Cited by

See all 69

Metadata

Authors
Reshetnyak, A. V., Rossi, P., Myasnikov, A. G., Sowaileh, M., Mohanty, J., Nourse, A., Miller, D. J., Lax, I., Schlessinger, J., & Kalodimos, C. G.
Venue
Nature
Published
2021-11-24
Volume
600
Issue
7887
Pages
153-157
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3216388661
Cited by
69
References
5
FWCI
2.68
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism for the activation of the anaplastic lymphoma kinase receptor. https://app.cochat.ai/papers/10.1038/s41586-021-04140-8
The paper
Reshetnyak, A. V., Rossi, P., Myasnikov, A. G., Sowaileh, M., Mohanty, J., Nourse, A., Miller, D. J., Lax, I., Schlessinger, J., & Kalodimos, C. G. (2021). Mechanism for the activation of the anaplastic lymphoma kinase receptor. Nature. https://doi.org/10.1038/s41586-021-04140-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.